ATE248190T1 - Chemoattraktion-auslösender faktor aus lymphozyten und dessen verwendungen - Google Patents
Chemoattraktion-auslösender faktor aus lymphozyten und dessen verwendungenInfo
- Publication number
- ATE248190T1 ATE248190T1 AT96918305T AT96918305T ATE248190T1 AT E248190 T1 ATE248190 T1 AT E248190T1 AT 96918305 T AT96918305 T AT 96918305T AT 96918305 T AT96918305 T AT 96918305T AT E248190 T1 ATE248190 T1 AT E248190T1
- Authority
- AT
- Austria
- Prior art keywords
- triggering factor
- chemoattraction
- lymphocyte
- lymphocyte chemoattraction
- triggering
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5446—IL-16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/974—Aids related test
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/480,156 US5807549A (en) | 1993-05-21 | 1995-06-07 | Lymphocyte chemoattractant factor and uses thereof |
PCT/US1996/009422 WO1996040786A1 (en) | 1995-06-07 | 1996-06-07 | Lymphocyte chemoattractant factor and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE248190T1 true ATE248190T1 (de) | 2003-09-15 |
Family
ID=23906878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96918305T ATE248190T1 (de) | 1995-06-07 | 1996-06-07 | Chemoattraktion-auslösender faktor aus lymphozyten und dessen verwendungen |
Country Status (7)
Country | Link |
---|---|
US (5) | US5807549A (de) |
EP (1) | EP0832132B1 (de) |
AT (1) | ATE248190T1 (de) |
CA (1) | CA2223262A1 (de) |
DE (1) | DE69629688T2 (de) |
ES (1) | ES2205037T3 (de) |
WO (1) | WO1996040786A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1155700A3 (de) * | 1993-05-21 | 2002-01-02 | Research Corporation Technologies, Inc | Chemoattraktion-auslösender Faktor aus Lymfozyten und dessen Verwendungen |
US6100387A (en) | 1997-02-28 | 2000-08-08 | Genetics Institute, Inc. | Chimeric polypeptides containing chemokine domains |
US6852508B1 (en) | 1997-02-28 | 2005-02-08 | Genetics Institute, Llc | Chemokine with amino-terminal modifications |
US6699466B1 (en) * | 1999-08-05 | 2004-03-02 | Research Corporation Technologies, Inc. | IL-16 antagonist peptides and DNA encoding the peptides |
US7998681B2 (en) * | 2000-10-06 | 2011-08-16 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Diagnosis and therapy of antibody-mediated inflammatory auto-immune disorders |
JP2004511510A (ja) * | 2000-10-16 | 2004-04-15 | ネオファーム、インコーポレイティッド | ミトキサントロンのリポソーム製剤 |
CA2552750C (en) | 2004-01-07 | 2021-11-09 | Chiron Corporation | M-csf-specific monoclonal antibody and uses thereof |
SE0403038D0 (sv) * | 2004-12-14 | 2004-12-14 | Tetra Laval Holdings & Finance | Anordning och metod för försegling |
ES2538036T3 (es) * | 2005-07-28 | 2015-06-16 | Novartis Ag | Uso de anticuerpo a M-CSF |
EP2311876A3 (de) * | 2005-07-28 | 2011-04-27 | Novartis AG | M-CSF-spezifischer monoklonaler Antikörper und Verwendungen davon |
MX2008005405A (es) * | 2005-10-28 | 2008-09-11 | Florida Internat University Bo | Anticuerpos quimericos equinos: humanos. |
TWI395754B (zh) | 2006-04-24 | 2013-05-11 | Amgen Inc | 人類化之c-kit抗體 |
JP5406027B2 (ja) | 2006-08-04 | 2014-02-05 | ノバルティス アーゲー | EphB3特異的抗体およびその使用 |
KR101433544B1 (ko) * | 2006-08-18 | 2014-08-27 | 노바르티스 아게 | Prlr 특이적 항체 및 그 용도 |
US20090130661A1 (en) * | 2006-09-28 | 2009-05-21 | Glass William G | Method for Detecting IL-16 Activity and Modulation of IL-16 Activity Based on Phosphorylated Stat-6 Proxy Levels |
EP2094305A4 (de) * | 2006-10-27 | 2011-01-05 | Centocor Ortho Biotech Inc | Verfahren zur behandlung von lungenleiden und bleomycin-assoziierter lungenfibrose |
AU2007329307B2 (en) | 2006-12-07 | 2012-08-02 | Novartis Ag | Antagonist antibodies against EphB3 |
EP2111412A2 (de) * | 2007-02-02 | 2009-10-28 | Amgen, Inc | Hepcidin und hepcidin-antikörper |
WO2009094551A1 (en) | 2008-01-25 | 2009-07-30 | Amgen Inc. | Ferroportin antibodies and methods of use |
JP2011519279A (ja) | 2008-05-01 | 2011-07-07 | アムジエン・インコーポレーテツド | 抗ヘプシジン抗体及び使用の方法 |
US20110217259A1 (en) * | 2010-03-03 | 2011-09-08 | Djordje Atanackovic | IL-16 as a target for diagnosis and therapy of hematological malignancies and solid tumors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4486530A (en) * | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
US4745051A (en) * | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
US4844893A (en) * | 1986-10-07 | 1989-07-04 | Scripps Clinic And Research Foundation | EX vivo effector cell activation for target cell killing |
DE69020914T2 (de) * | 1989-01-23 | 1996-03-07 | Abbott Lab | Monoklonale Antikörper von Ratten gegen menschliche Antigene und Verfahren zu deren Herstellung. |
US4918077A (en) * | 1989-01-25 | 1990-04-17 | E. I. Du Pont De Nemours & Co., Inc. | 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents |
US5514555A (en) * | 1993-03-12 | 1996-05-07 | Center For Blood Research, Inc. | Assays and therapeutic methods based on lymphocyte chemoattractants |
EP1155700A3 (de) * | 1993-05-21 | 2002-01-02 | Research Corporation Technologies, Inc | Chemoattraktion-auslösender Faktor aus Lymfozyten und dessen Verwendungen |
-
1995
- 1995-06-07 US US08/480,156 patent/US5807549A/en not_active Expired - Lifetime
- 1995-12-29 US US08/581,142 patent/US5976522A/en not_active Expired - Lifetime
- 1995-12-29 US US08/580,680 patent/US5766866A/en not_active Expired - Lifetime
- 1995-12-29 US US08/580,665 patent/US5965120A/en not_active Expired - Lifetime
- 1995-12-29 US US08/581,094 patent/US5869263A/en not_active Expired - Lifetime
-
1996
- 1996-06-07 ES ES96918305T patent/ES2205037T3/es not_active Expired - Lifetime
- 1996-06-07 AT AT96918305T patent/ATE248190T1/de active
- 1996-06-07 EP EP96918305A patent/EP0832132B1/de not_active Expired - Lifetime
- 1996-06-07 DE DE69629688T patent/DE69629688T2/de not_active Expired - Lifetime
- 1996-06-07 CA CA002223262A patent/CA2223262A1/en not_active Abandoned
- 1996-06-07 WO PCT/US1996/009422 patent/WO1996040786A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
US5807549A (en) | 1998-09-15 |
DE69629688T2 (de) | 2004-06-17 |
EP0832132B1 (de) | 2003-08-27 |
WO1996040786A1 (en) | 1996-12-19 |
US5976522A (en) | 1999-11-02 |
DE69629688D1 (de) | 2003-10-02 |
US5965120A (en) | 1999-10-12 |
EP0832132A1 (de) | 1998-04-01 |
CA2223262A1 (en) | 1996-12-19 |
US5766866A (en) | 1998-06-16 |
US5869263A (en) | 1999-02-09 |
ES2205037T3 (es) | 2004-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE248190T1 (de) | Chemoattraktion-auslösender faktor aus lymphozyten und dessen verwendungen | |
SE9503925D0 (sv) | Separationsmedium för IgG | |
DE69226431D1 (de) | Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor | |
ES2106195T3 (es) | Anticuerpo igg aglicosilado anti cd3. | |
DK0620854T3 (da) | Ekspression og oprensning af rekombinant opløselig vævsfaktor | |
DE69631468T2 (de) | Nachweis von antikörpern gegen bakterielle antigene durch fluoreszenz-polarisation | |
NO913186L (no) | Fremgangsmaate for anvendelse og syntese av peptider. | |
NZ237666A (en) | Hiv envelope (env) polypeptides, antibodies and compositions for treating aids | |
ATE282045T1 (de) | Verbindungen und verfahren zur hemmung von wechselwirkung zwischen alpha-catenin und beta- catenin | |
ATE476989T1 (de) | Humanisierter monoklonaler antikörper gegen von- willebrand faktor | |
ATE217086T1 (de) | Herstellung von photoprotein konjugaten und verfahren zu ihrer verwendung | |
DE69322783D1 (de) | Monoklonale Antikörper gegen Glykoprotein P | |
DE69615576D1 (de) | Polyklonaler antikörper gegen tryptase und reinigungsverfahren zur verwendung in einem immunoassay für menschliche tryptase | |
DE3580382D1 (de) | Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren. | |
DK0840620T3 (da) | IL-8-antagonister til behandling af astma | |
DK0580672T3 (da) | Syntetisk CDw52-(CAMPATH-1)-peptidantigen | |
FI925321A0 (fi) | Immunodiagnostiskt ledinflammationstest | |
FI20095269A (fi) | Lymfosyyttien sitoutumiseen vaikuttava ihmisen endoteelisolun molekyyli | |
ATE207935T1 (de) | Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid | |
DE69024871D1 (de) | Monoklonaler Antikörper gegen menschliches BCDF und Immuntestverfahren unter dessen Verwendung | |
GR970300022T1 (en) | Peptide capable of being recognised by antibodies recognising the C33 antigen of hepatitis C virus | |
TW288020B (en) | Monoclonal antibodies specific to methamphetamine, hybridoma producing the antibodies, kits containing the antibodies and uses thereof | |
Steele et al. | Serologic, biologic and western blot analysis of human IgE-binding factor derived from a T cell hybridoma maintained in protein-free medium. | |
GB9506425D0 (en) | New uses of monoclonal antibodies | |
CA2236900A1 (en) | Igg separation medium and novel protein a variant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0832132 Country of ref document: EP |